【摘要】 目的 探讨膀胱内药物灌注在膀胱癌术后复发中的疗效及安全性。 方法 应用细胞毒性药物或免疫增强制剂定期膀胱灌注，定期膀胱镜复查总疗程为2年。 结果 随访22～26个月，BCG+IL-2和TPH组手术后1、2年肿瘤复发率分别为4.6%、15.1%和4.3%、8.9%。 结论 膀胱癌术后定期膀胱灌注预防浅表性膀胱癌术后复发疗效满意，是膀胱癌治疗不可少的环节。

    【关键词】 膀胱肿瘤 膀胱灌注

    Postoperative intravesica linstillation for the preventing recurrence of superficial bladder carcinoma

    Yu Chaoying

    Department of Urology affiliated Hospital of Binzhou Medicalaaology，Binzhou256603.

    【Abstract】 Objective To evaluate effects and safety of intravesicial instillation on preventing tumor recu-urence after operation of superficial bladder carcinoma.Methods 86patients with superficial bladder carcinoma were instilled BCG+IL-2or TPH ......